pirinixil has been researched along with clofibrate in 5 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 3 (60.00) | 18.7374 |
| 1990's | 2 (40.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Branzoli, U; Carganico, G; Chiari, A; Cozzi, P; Lovisolo, PP; Orsini, G; Pillan, A | 1 |
| Cerutti, S; D'Atri, G; Gomarasca, P; Scolastico, C; Sirtori, CR; Tronconi, G | 1 |
| Reddy, JK; Schiestl, RH | 1 |
| D'Atri, G; Galimberti, E; Gomarasca, P; Kritchevsky, D; Sirtori, CR | 1 |
| Brady, EP; Chandar, N; Eagon, PK; Elm, MS; Kelly, RH; Rao, B; Rao, KN; Shinozuka, H | 1 |
5 other study(ies) available for pirinixil and clofibrate
| Article | Year |
|---|---|
N-imidazolylchroman-4-ones, N-imidazolyl-1-tetralones, and their alcohols as hypolipemic agents raising high-density lipoproteins.
Topics: Alcohols; Animals; Cholesterol; Enzyme Induction; Hypercholesterolemia; Hypolipidemic Agents; Imidazoles; In Vitro Techniques; Lipoproteins, HDL; Liver; Male; Microbodies; Microsomes, Liver; Organ Size; Pyrimidines; Rats; Rats, Inbred Strains; Structure-Activity Relationship | 1986 |
Pharmacological profile of BR-931, a new hypolipidemic agent that increases high-density lipoproteins.
Topics: Acetamides; Animals; Arteriosclerosis; Cholesterol; Clofibrate; Dogs; Dose-Response Relationship, Drug; Hyperlipidemias; Hypolipidemic Agents; Lipid Mobilization; Lipoproteins, HDL; Liver; Male; Mice; Pyrimidines; Rabbits; Rats; Triglycerides | 1978 |
Effect of peroxisome proliferators on intrachromosomal and interchromosomal recombination in yeast.
Topics: Anticholesteremic Agents; Chromosomes, Fungal; Clofibrate; Hypolipidemic Agents; Microbodies; Pyrimidines; Recombination, Genetic; Saccharomyces cerevisiae | 1990 |
Clofibrate, pirinixil (BR 931) and WY-14,643 do not affect body cholesterol in Sprague-Dawley rats.
Topics: Animals; Anticholesteremic Agents; Aorta; Cholesterol; Cholesterol, Dietary; Clofibrate; Drug Evaluation, Preclinical; Intestinal Mucosa; Kidney; Liver; Lung; Male; Myocardium; Pyrimidines; Rats; Spleen; Thioacetamide | 1980 |
Hepatic hyperplasia and cancer in rats: metabolic alterations associated with cell growth.
Topics: Animals; Blotting, Western; Carcinogens; Cell Division; Cholesterol; Clofibrate; Diethylhexyl Phthalate; Glucosephosphate Dehydrogenase; Hydroxymethylglutaryl CoA Reductases; Hyperplasia; Liver; Liver Neoplasms, Experimental; Malate Dehydrogenase; Male; NADP; Pentose Phosphate Pathway; Pyrimidines; Rats; Rats, Inbred F344; Receptors, LDL; RNA, Messenger | 1997 |